Matches in Wikidata for { <http://www.wikidata.org/entity/Q38406862> ?p ?o ?g. }
- Q38406862 description "2015 nî lūn-bûn" @default.
- Q38406862 description "2015年の論文" @default.
- Q38406862 description "2015年論文" @default.
- Q38406862 description "2015年論文" @default.
- Q38406862 description "2015年論文" @default.
- Q38406862 description "2015年論文" @default.
- Q38406862 description "2015年論文" @default.
- Q38406862 description "2015年论文" @default.
- Q38406862 description "2015年论文" @default.
- Q38406862 description "2015年论文" @default.
- Q38406862 description "2015年论文" @default.
- Q38406862 description "2015年论文" @default.
- Q38406862 description "2015年论文" @default.
- Q38406862 description "2015년 논문" @default.
- Q38406862 description "article científic" @default.
- Q38406862 description "article scientific" @default.
- Q38406862 description "article scientifique" @default.
- Q38406862 description "articol științific" @default.
- Q38406862 description "articolo scientifico" @default.
- Q38406862 description "artigo científico" @default.
- Q38406862 description "artigo científico" @default.
- Q38406862 description "artigo científico" @default.
- Q38406862 description "artikel ilmiah" @default.
- Q38406862 description "artikull shkencor" @default.
- Q38406862 description "artikulong pang-agham" @default.
- Q38406862 description "artykuł naukowy" @default.
- Q38406862 description "artículo científico" @default.
- Q38406862 description "artículu científicu espublizáu en 2015" @default.
- Q38406862 description "bilimsel makale" @default.
- Q38406862 description "bài báo khoa học" @default.
- Q38406862 description "naučni članak" @default.
- Q38406862 description "scienca artikolo" @default.
- Q38406862 description "scientific article published on August 2015" @default.
- Q38406862 description "scientific article published on August 2015" @default.
- Q38406862 description "scientific article published on August 2015" @default.
- Q38406862 description "teaduslik artikkel" @default.
- Q38406862 description "tieteellinen artikkeli" @default.
- Q38406862 description "tudományos cikk" @default.
- Q38406862 description "vedecký článok" @default.
- Q38406862 description "vetenskaplig artikel" @default.
- Q38406862 description "videnskabelig artikel" @default.
- Q38406862 description "vitenskapelig artikkel" @default.
- Q38406862 description "vitskapeleg artikkel" @default.
- Q38406862 description "vědecký článek" @default.
- Q38406862 description "wetenschappelijk artikel" @default.
- Q38406862 description "wissenschaftlicher Artikel" @default.
- Q38406862 description "επιστημονικό άρθρο" @default.
- Q38406862 description "мақолаи илмӣ" @default.
- Q38406862 description "наукова стаття, опублікована в серпні 2015" @default.
- Q38406862 description "научна статия" @default.
- Q38406862 description "научная статья" @default.
- Q38406862 description "научни чланак" @default.
- Q38406862 description "научни чланак" @default.
- Q38406862 description "מאמר מדעי" @default.
- Q38406862 description "مقالة علمية نشرت في أغسطس 2015" @default.
- Q38406862 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38406862 description "บทความทางวิทยาศาสตร์" @default.
- Q38406862 description "სამეცნიერო სტატია" @default.
- Q38406862 name "Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy" @default.
- Q38406862 name "Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy" @default.
- Q38406862 name "Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy" @default.
- Q38406862 type Item @default.
- Q38406862 label "Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy" @default.
- Q38406862 label "Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy" @default.
- Q38406862 label "Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy" @default.
- Q38406862 prefLabel "Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy" @default.
- Q38406862 prefLabel "Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy" @default.
- Q38406862 prefLabel "Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy" @default.
- Q38406862 P1433 Q38406862-FA8D880A-84B4-4DA6-8479-52E3224DFCD5 @default.
- Q38406862 P1476 Q38406862-750FD390-8919-4C33-AA8C-092211FA5647 @default.
- Q38406862 P2093 Q38406862-2D47B3E4-A566-48F8-B1D8-8C25B48F3646 @default.
- Q38406862 P2093 Q38406862-320C1156-19B1-4150-BFA6-B44E8059D8BE @default.
- Q38406862 P2093 Q38406862-529C930B-660D-4F7F-8B44-25C5361C493F @default.
- Q38406862 P2093 Q38406862-5A200923-F2D9-444C-9406-DEFB2EE01CB4 @default.
- Q38406862 P2093 Q38406862-80DA40F2-8EFC-4FD6-9E17-2B0B45B6EAE1 @default.
- Q38406862 P2093 Q38406862-BF51FBC5-4AB3-4549-B50E-B4D083141948 @default.
- Q38406862 P2093 Q38406862-CDD7F279-6B31-4F08-89AE-3F8754E1F621 @default.
- Q38406862 P2093 Q38406862-E9608B11-CAC0-4156-9447-4906C991F691 @default.
- Q38406862 P2093 Q38406862-EA9564DE-1FDB-48B0-A63C-8E6F833923EE @default.
- Q38406862 P2093 Q38406862-F0F08D29-44FA-4227-A302-135AF1170C6D @default.
- Q38406862 P304 Q38406862-981844DA-FDCF-41B8-860E-F83193FDE2F5 @default.
- Q38406862 P31 Q38406862-438E0107-B8E6-40F0-829F-6FDE3DA3E4BE @default.
- Q38406862 P356 Q38406862-0D07B599-06E5-48CF-AAF6-6C2B63538C16 @default.
- Q38406862 P407 Q38406862-F02599D2-7676-40DF-9A17-90FA7BB7DE29 @default.
- Q38406862 P433 Q38406862-1F3C397C-7E62-40E6-BF1B-21C57204FE89 @default.
- Q38406862 P478 Q38406862-197A2F19-3D73-4C9E-8C83-B1A26CE3B0F5 @default.
- Q38406862 P50 Q38406862-926CD565-9843-4E7B-AFC5-9753BE139EB6 @default.
- Q38406862 P577 Q38406862-4D1EE6E5-3772-461D-B226-5FAC8127851F @default.
- Q38406862 P698 Q38406862-D4207B68-38C8-43EF-A7EC-7BFC8C045DB8 @default.
- Q38406862 P921 Q38406862-17148A01-8AA8-4FC1-B70D-3DCFFE5105A2 @default.
- Q38406862 P356 JRHEUM.141580 @default.
- Q38406862 P698 26233509 @default.
- Q38406862 P1433 Q7743623 @default.
- Q38406862 P1476 "Results from a Phase IIA Parallel Group Study of JNJ-40346527, an Oral CSF-1R Inhibitor, in Patients with Active Rheumatoid Arthritis despite Disease-modifying Antirheumatic Drug Therapy" @default.
- Q38406862 P2093 "Andrew Greenspan" @default.
- Q38406862 P2093 "Caly Chien" @default.
- Q38406862 P2093 "Carl L Manthey" @default.
- Q38406862 P2093 "Carol Franks" @default.
- Q38406862 P2093 "Elizabeth Hsia" @default.
- Q38406862 P2093 "Mark C Genovese" @default.